Onalespib lactate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Onalespib lactate, covering 2022-06-22 to 2022-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer [Phase 1, Phase 2]